Abstract

The combined phenotype of thrombocytopenia accompanied by intellectual disability in patients with a de novo heterozygous mutation, i.e., p.Tyr64Cys in CDC42, signifies a clinically recognizable novel syndrome that has been eponymized as “Takenouchi-Kosaki syndrome” (OMIM #616737). In the present study, a detailed phenotypic analysis performed for a total of five patients with Takenouchi-Kosaki syndrome revealed that intellectual disability, macrothrombocytopenia, camptodactyly, structural brain abnormalities with sensorineural deafness, hypothyroidism, and frequent infections comprise the cardinal features of this condition. A morphologic analysis of platelets derived from three affected individuals was performed using electron microscopy. The platelets of the three patients were large and spherical in shape. Furthermore, platelet α-granules were decreased, while vacuoles were increased. We further performed a functional analysis of p.Tyr64Cys in CDC42 through CRISPR/Cas9-mediated gene editing in a Caenorhabditis elegans model. This functional analysis suggested that the mutant allele has hypomorphic effects. Takenouchi-Kosaki syndrome is clinically recognizable by the combined phenotype of intellectual disability, macrothrombocytopenia, camptodactyly, structural brain abnormalities with sensorineural deafness, hypothyroidism, and frequent infections as well as the identification of a heterozygous de novo mutation in CDC42, i.e., p.Tyr64Cys.

Details

Title
Pathogenetic basis of Takenouchi-Kosaki syndrome: Electron microscopy study using platelets in patients and functional studies in a Caenorhabditis elegans model
Author
Uehara Tomoko 1 ; Suzuki, Hidenori 2 ; Okamoto Nobuhiko 3 ; Kondoh Tatsuro 4 ; Ahmad, Ayesha 5 ; O’Connor Bridget C 5 ; Yoshina Sawako 6 ; Mitani Shohei 6   VIAFID ORCID Logo  ; Kosaki Kenjiro 1 ; Takenouchi Toshiki 7   VIAFID ORCID Logo 

 Keio University School of Medicine, Center for Medical Genetics, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959) 
 Graduate School of Medicine, Nippon Medical School, Division of Morphological and Biomolecular Research, Tokyo, Japan (GRID:grid.410821.e) (ISNI:0000 0001 2173 8328) 
 Osaka Women’s and Children’s Hospital, Department of Medical Genetics, Osaka, Japan (GRID:grid.410821.e) 
 Misakaenosono Mutsumi Developmental, Medical, and Welfare Center, Isahaya, Japan (GRID:grid.410821.e) 
 University of Michigan, Division of Pediatric Genetics, Metabolism and Genomic Medicine, Department of Pediatrics, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370) 
 Tokyo Women’s Medical University School of Medicine, Department of Physiology, Tokyo, Japan (GRID:grid.410818.4) (ISNI:0000 0001 0720 6587) 
 Keio University School of Medicine, Department of Pediatrics, Tokyo, Japan (GRID:grid.26091.3c) (ISNI:0000 0004 1936 9959) 
Publication year
2019
Publication date
Dec 2019
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2191353503
Copyright
This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.